T1	Participants 55 72	autistic disorder
T2	Participants 308 359	pediatric subjects receiving aripiprazole treatment
T3	Participants 560 608	subjects with autistic disorder, aged 6-17 years
T4	Participants 913 936	316 randomized subjects
T5	Participants 2092 2108	younger subjects
T6	Participants 2397 2444	children and adolescents with autistic disorder
